---

---

entities : Teva pharmaceutical industries ltd    crawled time : 12:00   

save search

---

Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
Published: 2024-02-15 (Crawled : 12:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M |

n/a

| -18.92% | O: 0.32% H: 2.98% C: 0.32%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -7.24% | O: -0.19% H: 1.6% C: 1.24%
KMDA | News | $5.05 -0.98% -0.99% 27K |

Health Technology

| -15.22% | O: 1.66% H: 1.96% C: 0.49%
avt04 stelara biosimilar expected global market

---

Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
Published: 2024-01-30 (Crawled : 12:00) - prnewswire.com
TARO | $42.25 0.14% 0.0% 17K |

Health Technology

| -1.95% | O: -0.07% H: 1.68% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -9.44% | O: 0.05% H: 0.05% C: -1.31%
management

---

Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki (AVT04), the First Biosimilar of Stelara® (ustekinumab)
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M |

n/a

| 41.13% | O: 0.33% H: 3.87% C: -0.55%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -1.68% | O: 0.17% H: 0.0% C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K |

Health Technology

| 6.37% | O: 0.21% H: 1.67% C: 1.25%
avt04 stelara pharma biosimilar authorization

---

Addiction therapeutics market size to increase by USD 9.86 billion between 2022 and 2027; Driven by high consumption of alcohol, tobacco, and opioid products - Technavio
Published: 2023-03-03 (Crawled : 12:00) - prnewswire.com
MNK | $0.3402 -0.06% 540K |

n/a

| -95.33% | O: 0.34% H: 4.11% C: 4.11%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 17.61% | O: 0.09% H: 1.57% C: 1.51%
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -0.09% | O: 0.45% H: 0.45% C: -0.45%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 14.52% | O: -0.38% H: 0.65% C: 0.61%
opioid therapeutics market

---

BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer
Published: 2023-01-04 (Crawled : 12:00) - ir.biolinerx.com
BLRX | $0.6564 2.55% 2.48% 190K |

Health Technology

| -1.54% | O: 0.66% H: 6.97% C: 6.02%
medical

---

European Alzheimer's Disease Therapeutics and Diagnostics Industry to 2028 - Players Include Allergan, Novartis, Pfizer and Siemens Healthineers
Published: 2023-01-04 (Crawled : 12:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 0.94% | O: 0.86% H: 0.04% C: -1.25%
disease alzheimer's diagnostics therapeutics

---

Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT
Published: 2022-12-16 (Crawled : 12:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M |

n/a

| 59.13% | O: -3.75% H: 5.26% C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K |

Health Technology

| 25.49% | O: -0.25% H: 0.99% C: -3.95%
announcement

---

Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT to headline field
Published: 2022-12-16 (Crawled : 12:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M |

n/a

| 59.13% | O: -3.75% H: 5.26% C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K |

Health Technology

| 25.49% | O: -0.25% H: 0.99% C: -3.95%
announcement

---

Active Pharmaceutical Ingredients Market to be Worth $353.0 Billion by 2030: Million Insights
Published: 2022-12-05 (Crawled : 12:00) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -0.45% | O: -0.27% H: 0.0% C: -1.97%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -40.47% | O: -0.25% H: 0.61% C: -0.28%
ALB | $112.15 0.31% -0.13% 2M |

Process Industries

| -59.72% | O: -1.03% H: 0.36% C: -5.73%
active market

---

Global Osteoporosis Drugs Market Report 2022: Anabolic Drug Developments Show High Potential to Reshape Sector
Published: 2022-11-07 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 25.0% | O: -3.13% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 20.04% | O: -3.09% H: 0.72% C: -0.09%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 110.06% | O: 0.17% H: 2.51% C: 1.97%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -1.53% | O: -0.33% H: 3.48% C: 3.31%
drug global report potential market osteoporosis

---

Teva Reports Third Quarter 2022 Financial Results
Published: 2022-11-03 (Crawled : 12:00) - biospace.com/
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
teva financial results

---

Global Enzyme Inhibitor Market Report 2022-2026 & 2031: Major Companies Such as Abbott, Amgen, AstraZeneca, Bayer, & F. Hoffmann-La Roche are Focused on Strategic Partnerships to Meet Demand
Published: 2022-11-03 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 12.75% | O: -2.33% H: 3.2% C: 3.2%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 111.51% | O: -0.25% H: 2.48% C: 2.15%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| 8.53% | O: -1.25% H: 0.21% C: -0.37%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 14.35% | O: -1.31% H: 1.98% C: 1.71%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -1.51% | O: -0.18% H: 0.03% C: -0.99%
global companies report roche market

---

Antidepressant Drugs Market Size to Grow by USD 5.22 Bn, Driven by Rising Prevalence of Depression - Technavio
Published: 2022-11-01 (Crawled : 12:00) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 9.77% | O: 0.59% H: 1.18% C: 0.59%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 34.46% | O: 3.08% H: 4.93% C: 2.99%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 12.81% | O: 0.18% H: 0.71% C: 0.17%
depression market

---

Erectile Dysfunction Drugs Market to Surpass Around USD 4079.9 Million by 2028, Says Brandessence Market Research
Published: 2022-09-23 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 21.97% | O: 5.45% H: 0.0% C: -8.46%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 141.51% | O: 0.32% H: 1.06% C: -0.13%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 16.57% | O: -1.69% H: 0.0% C: 0.0%
research market

---

Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis
Published: 2022-09-16 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 16.59% | O: 0.74% H: 0.91% C: -0.74%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 11.9% | O: -0.52% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 27.67% | O: 0.62% H: 1.12% C: 0.01%
NTLA | $21.57 1.17% 1.16% 1.4M |

Health Technology

| -68.91% | O: -3.76% H: 0.36% C: -0.44%
ntla-2001 treatment ongoing crispr therapy study

---

Quinidine Sulfate Market Size to Grow by USD 427.29 mn, North America to be Largest Contributor to Market Growth - Technavio
Published: 2022-09-15 (Crawled : 12:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
america growth market

---

Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
Published: 2022-09-15 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 10.75% | O: 1.6% H: 0.0% C: -6.5%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 12.76% | O: 0.4% H: 0.84% C: 0.37%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 29.18% | O: -0.41% H: 3.27% C: 1.6%
ALNY | $144.315 -0.58% -0.59% 700K |

Health Technology

| -30.31% | O: -0.9% H: 2.16% C: 1.01%
ongoing report nash study phase 1

---

Value of Gout Therapeutics Market Estimated at US$ 4.9 Bn by 2031, TMR Study
Published: 2022-09-07 (Crawled : 12:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 47.07% | O: 4.71% H: 0.0% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -1.65% | O: -1.5% H: 1.21% C: 1.06%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 16.69% | O: 0.66% H: 0.88% C: 0.8%
therapeutics study market

---

Narcolepsy Drugs Market Size to Grow by USD 1.60 billion with 44% of the Contribution from North America - Technavio
Published: 2022-09-07 (Crawled : 12:00) - prnewswire.com
JAZZ | $109.96 0.63% 0.63% 760K |

Health Technology

| -29.03% | O: -0.62% H: 1.65% C: 1.35%
AVDL | $17.33 -0.29% -0.29% 1.3M |

Health Technology

| 171.99% | O: 1.1% H: 0.15% C: -8.36%
america narcolepsy market

---

Late-Breaking Dupixent® (dupilumab) Data at ERS 2022 Show Consistent Efficacy and Safety Profile for Up to Two Years in Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Published: 2022-09-05 (Crawled : 12:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
dupixent children

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---